40 results about "Lilium brownii" patented technology

The invention discloses an application of bulbus lilii glycoside B. The application is that bulbus lilii glycoside B is used as a unique active component or one of the active components to prepare a product for preventing or / and treating skin photoaging diseases. Experimental results of the invention show that lilium brownii glycoside B can significantly improve the cell viability of UVA-induced human skin fibroblasts, can reduce the number of beta-galactosidase positive cells in the UVA-induced human skin fibroblasts and reduce lipofuscin deposition, and can significantly improve the photoaging of the UVA-induced skin fibroblasts. Meanwhile, the skin photoaging grading of the back of a C57BL / 6 mouse induced by UVA can be remarkably improved. Therefore, the bulbus lilii glycoside B is expected to be used as an active ingredient for preparing medicines or cosmetics for preventing or / and treating the skin photoaging diseases, and particularly has important significance and remarkable application value for preventing or / and treating the UVA-induced skin photoaging diseases.

This invention discloses a Zhishu Yangwei tablet for chronic gastritis and its granule dry-compression tableting process, relating to the field of traditional Chinese medicine preparation technology. The Yangwei tablet is made from the following raw materials in parts by weight: Codonopsis pilosula 35-45 parts, stir-fried Atractylodes macrocephala 18-22 parts, Poria cocos 18-22 parts, Glycyrrhiza uralensis 8-12 parts, Amomum villosum 18-22 parts, Lindera strychnifolia 18-22 parts, Salvia miltiorrhiza 45-55 parts, roasted Aucklandia lappa 18-22 parts, Paeonia lactiflora 18-22 parts, stir-fried Citrus aurantium 18-22 parts, Magnolia officinalis 28-32 parts, Lilium brownii 35-45 parts, and stir-fried chicken gizzard lining 18- 22 parts, dried plum 45-55 parts, Coptis chinensis 8-12 parts, hawthorn 35-45 parts, magnesium stearate 5-7 parts, sucrose 28-32 parts; This invention uses low-temperature dynamic extraction technology to replace the traditional high-temperature decoction process, effectively reducing the decomposition loss of heat-sensitive active ingredients such as tanshinone IIA and ursolic acid, and improving the bioavailability of the drug. It also uses membrane concentration and spray drying technology to replace the traditional atmospheric pressure concentration and oven drying process, shortening the production cycle, reducing energy consumption, and avoiding the degradation of active ingredients caused by prolonged heating of materials.

This invention relates to a traditional Chinese medicine preparation for treating infectious bursal disease (IBD), its preparation method, and its application. The preparation comprises the following components: Astragalus membranaceus 45-50 parts, Rehmannia glutinosa 30-45 parts, Isatis indigotica 25-30 parts, Isatis tinctoria 25-30 parts, Gypsum fibrosum 10-45 parts, Lonicera japonica 10-20 parts, Forsythia suspensa 10-30 parts, Taraxacum mongolicum 10-20 parts, Atractylodes macrocephala 15-20 parts, Paeonia lactiflora 15-30 parts, Lilium brownii 15 parts, Anemarrhena asphodeloides 15 parts, and Glycyrrhiza uralensis 10-30 parts. The preparation is achieved through extraction and concentration processes and is effective in treating IBD in chickens caused by both traditional infectious bursal disease virus (IBDV) and novel variant infectious bursal disease virus (nvvIBDV). This medicine significantly improves the cure rate against both traditional and variant strains, showing a particularly significant advantage in treating variant strains.

This invention provides a traditional Chinese medicine composition for treating ulcerative colitis, belonging to the field of traditional Chinese medicine pharmaceutical technology. The composition is obtained through rational formulation based on the principles of syndrome differentiation and treatment in traditional Chinese medicine, specifically composed of Forsythia suspensa, Lilium brownii, Lysimachia christinae, Sesamum indicum, Prickly ash, Pueraria lobata, Centella asiatica, Viola yedoensis, Houttuynia cordata, Portulaca oleracea, Litsea cubeba, Cirsium japonicum, Schizonepeta tenuifolia, Morus alba root, Lophatherum gracile, Lygodium japonicum, and Capsella bursa-pastoris. This invention's composition exhibits significant anti-inflammatory and de-inflammatory effects, and can repair and improve the integrity of colonic tissue structure, enhance intestinal barrier function, and achieve both symptomatic and root-cause treatment of ulcerative colitis. Simultaneously, this invention's composition has a high efficacy and cure rate in treating ulcerative colitis, and significantly alleviates symptoms such as diarrhea, bloody stools, abdominal pain, abdominal distension, anal burning, and tenesmus, greatly reducing patient suffering.

The present invention discloses a composition, which comprises mixed extract A and mixed extract B, and the mass ratio of mixed extract A to mixed extract B is 1:4 - 4:1; wherein mixed extract A is prepared from 20 - 40 parts by weight of Phyllanthus emblica, 10 - 30 parts by weight of honeysuckle, 5 - 15 parts by weight of fresh Imperata cylindrica root, and 5 - 15 parts by weight of dandelion; mixed extract B is prepared from 5 - 15 parts by weight of Cassia obtusifolia, 20 - 40 parts by weight of Cynara scolymus, 5 - 15 parts by weight of Lilium brownii, and 10 - 30 parts by weight of Cornus officinalis; when the composition is applied to the preparation of drugs for reducing uric acid and preventing and treating gout, the experimental results show that the composition can significantly inhibit uric acid production, promote uric acid excretion, thereby reducing blood uric acid, and at the same time has the effects of significantly reducing gouty joint swelling, inhibiting joint inflammation and oxidative stress state. In addition, the composition of the present invention is derived from medicinal and edible homologous plant raw materials, and is safe, convenient to eat and has no toxic side effects.

This invention discloses a traditional Chinese medicine composition for treating allergic rhinitis and its application, relating to the field of allergic rhinitis treatment technology. It comprises: 12-18 parts Astragalus membranaceus, 8-12 parts Codonopsis pilosula, 6-10 parts medicated leaven (processed with styrax), 5-9 parts Lilium brownii, 5-10 parts Platycodon grandiflorus, 4-7 parts Prunus mume, 3-5 parts Cicadae periostracum, 2-4 parts Xanthium sibiricum (processed with styrax), and 2-4 parts Glycyrrhiza uralensis (processed with styrax). This invention scientifically combines Astragalus membranaceus and Codonopsis pilosula (for invigorating qi and strengthening the exterior), Xanthium sibiricum (processed with styrax) and Cicadae periostracum (for dispelling wind and opening the orifices), Lilium brownii and Prunus mume (for astringing the lungs and nourishing the blood), medicated leaven (processed with styrax) for strengthening the spleen and harmonizing the middle jiao, and Platycodon grandiflorus and Glycyrrhiza uralensis (processed with styrax) for harmonizing the various herbs. The proportions of each group can produce a synergistic effect, which can not only effectively relieve the external symptoms of allergic rhinitis such as nasal congestion, runny nose, sneezing, and nasal itching, but also improve the patient's allergic constitution and enhance immune tolerance by invigorating qi and strengthening the exterior, regulating lung and spleen functions, thereby reducing the recurrence rate and achieving a therapeutic effect that addresses both the symptoms and the root cause of allergic rhinitis.

The present invention belongs to the technical field of food detection, and discloses a method for rapidly identifying lily powder based on an electronic tongue and electron microscopy multimodal technology. By collecting the array data of the electronic tongue taste sensors and the image data under a scanning electron microscope, and performing preprocessing on the data such as first-order derivative, vector normalization, filtering and smoothing, the dimension is reduced and the characteristic information that can most represent the sample is extracted. A discriminant analysis model for rapidly identifying Lilium brownii var. viridulum, Lilium bulbocapicum, and Lilium speciosum is constructed by a clustering algorithm, and a data model of different types of lily powder is constructed, which is beneficial to realizing the quality monitoring and evaluation of lilies throughout the whole process of lily powder production, processing, circulation, and consumption. This detection method does not require the use of a large amount of reagents, is green and environmentally friendly, has simple operation, good reproducibility, stable and accurate results, and can realize rapid on-line detection and real-time evaluation feedback.

The invention discloses rhizoma bletillae spot-fading powder and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine, and the rhizoma bletillae spot-fading powder comprises the following raw materials in parts by weight: 10-30 parts of rhizoma bletillae, 10-30 parts of radix astragali, 10-30 parts of radix notoginseng, 10-30 parts of lily, 10-30 parts of rose, 10-30 parts of radix paeoniae alba, 10-30 parts of radix angelicae, 10-30 parts of pearl powder, 10-30 parts of coix seed and 10-30 parts of liquorice. The traditional Chinese medicine composition can repair the skin barrier function, enhance the skin resistance, reduce external stimulation, relieve sensitive redness, regulate water-oil balance, improve the problems of much oil and coarse pores and maintain the healthy and stable state of the skin, is prepared from pure traditional Chinese medicines, is mild in conditioning, does not have any toxic or side effect after being used for a long time, and has a repairing effect on hormone-dependent skin.

The present application relates to the technical field of transgenic engineering, and particularly discloses a lily LpLBD4 gene, a recombinant expression vector and application, wherein the nucleotide sequence of the LpLBD4 gene is shown as SEQ ID NO. 1, the full-length nucleotide sequence of the ORF is shown as SEQ ID NO. 2, and the amino acid sequence of the encoded protein is shown as SEQ ID NO. 3. The present application significantly enhances the callus formation ability by overexpressing the lily LpLBD4 gene.

This invention discloses a food-medicine composition with the effects of clearing the lungs, resolving phlegm, dispersing blood stasis, and eliminating nodules, belonging to the fields of functional food therapy and traditional Chinese medicine lung conditioning technology. This invention completely abandons the defects of traditional low-dose health care formulas. All raw materials are strictly formulated according to the legally prescribed therapeutic doses in the Chinese Pharmacopoeia and the conventional dosages in traditional Chinese medicine clinical prescriptions for pulmonary nodules. It uses high doses of Houttuynia cordata and fresh Imperata cylindrica root as the core heat-clearing and nodule-dispersing principal herbs, combined with sufficient amounts of Platycodon grandiflorus, Citrus reticulata peel, and Citrus reticulata peel to clear the lungs and resolve phlegm; a high proportion of Lilium brownii, Polygonatum odoratum, and Ophiopogon japonicus to nourish yin and protect the lungs; and Prunus persica to invigorate blood and disperse blood stasis, constructing a three-level pharmacopoeia-compliant dosage system. This invention features a rigorous formulation, a balanced combination of hot and cold properties of the medicinal ingredients, and sufficient potency. It breaks through the technical bottleneck of traditional dietary therapy formulas that cannot deeply disperse stagnation. It can effectively intervene in the phlegm and blood stasis in the lungs, improve pulmonary nodules, and eliminate long-term symptoms of lung heat and excessive phlegm, chest tightness, and dry throat. Its efficacy can be verified through multiple dimensions, including human trials, animal pharmacology experiments, and real clinical cases. The technology is innovative and practical, and it can be used as a high-end conditioning food for sub-healthy lungs in the general public, as well as a long-term standardized dietary intervention program for people with pulmonary nodules. It has extremely high value for industrialization and promotion.

This invention relates to the field of traditional Chinese medicine (TCM) technology, specifically providing a TCM composition, preparation, and application for improving ovarian function. The TCM composition of this invention, by weight, comprises: 10-50 parts of Cuscuta chinensis, 5-35 parts of Cistanche deserticola, 10-50 parts of Lycium barbarum, 10-50 parts of Polygonatum sibiricum, 10-50 parts of Codonopsis pilosula, 5-25 parts of Atractylodes macrocephala, 5-25 parts of Nelumbo nucifera leaf, 5-25 parts of Dendrobium nobile, 5-30 parts of Lilium brownii, 5-30 parts of Rosa rugosa, 5-30 parts of Rosa chinensis var. chinensis, 5-25 parts of Paeonia lactiflora, 10-50 parts of Salvia miltiorrhiza, and 3-10 parts of Celosia argentea. Compared with existing technologies, the components of the TCM composition of this invention are scientifically formulated and synergistically act, exhibiting a better therapeutic effect on improving ovarian dysfunction. The preparation method is simple, with significant efficacy and no toxic side effects.

The invention provides elicitor peptide LilyPep1 and application of the elicitor peptide LilyPep1 in promotion of lily tissue culture and rapid propagation, and relates to the technical field of plant tissue culture, the amino acid sequence of the LilyPep1 is as shown in SEQ ID NO.2, when the elicitor peptide LilyPep1 is applied to lily tissue culture, the tissue culture efficiency is remarkably improved, and the budding rate, the multiplication coefficient and the rooting rate in primary culture, subculture, multiplication culture and rooting culture are remarkably increased; compared with the lilium brownii without the polypeptide, the lilium brownii without the polypeptide is remarkably improved by 17.59%, 80.56% and 25.33% respectively, the elicitor peptide LilyPep1 is applied to lilium brownii tissue culture for the first time, and a brand-new technical approach for promoting lilium brownii tissue culture and rapid propagation is created.

The invention discloses a traditional Yi medicine composition for promoting generation and growth of natural calculus bovis and a preparation method of the traditional Yi medicine composition. Comprising the following components in parts by mass: 20-40 parts of lucid ganoderma, 20-40 parts of fructus cannabis, 20-40 parts of pinenut kernels, 20-40 parts of cortex acanthopanacis, 20-40 parts of radix angelicae pubescentis, 20-40 parts of rhizoma atractylodis, 20-40 parts of mangnolia officinalis, 20-40 parts of poria cocos, 20-40 parts of polyporus umbellatus, 20-40 parts of spina date seeds, 20-40 parts of platycladi seeds, 20-40 parts of angelica sinensis, 20-40 parts of prepared rehmannia roots, 20-40 parts of white chrysanthemum, 20-40 parts of polygonum multiflorum, 20-40 parts of eucommia ulmoides, 20-40 parts of astragalus membranaceus, 20-40 parts of rhizoma atractylodis macrocephalae, 20-40 parts of Chinese yam and 20-40 parts of lily. 20 to 40 parts of radix ophiopogonis; compared with the prior art, the cattle feed has the advantages that the cattle feed has the function of promoting generation and growth of natural calculus bovis, and experiments prove that calculus bovis is almost not generated in cattle bodies bred conventionally; calculus bovis can grow in cattle with the traditional Chinese medicine composition added in diet. The amount of bezoar produced by each cow is about 100g, and the content of bilirubin in bezoar is more than 70%.

This invention belongs to the technical field of traditional Chinese medicine processing methods, and discloses a method for processing nine-times-processed Astragalus membranaceus, which is entirely made from medicinal and edible ingredients. The method includes: S1, pretreatment of the main ingredient: taking Astragalus membranaceus slices and drying them at low temperature until the moisture content is ≤12%; S2, adding auxiliary ingredients in eight stages of decoction and drying: adding Poria cocos, Platycodon grandiflorus, Crataegus pinnatifida, Ophiopogon japonicus, Lilium brownii, dried ginger, Perilla frutescens leaves, and Prunus mume to the pretreated Astragalus membranaceus slices for multiple stages of decoction and drying, drying each stage until the moisture content is ≤12%; S3, honey-coated stir-frying, steaming, and shaping: first, stir-frying the Astragalus membranaceus slices dried after the last decoction and soaking with honey solution, then steaming, and allowing them to settle and blend to obtain the finished product. The auxiliary ingredients used in this invention for processing nine-times-processed Astragalus membranaceus are all medicinal and edible ingredients, ensuring high safety; the key parameters for each step are clearly defined, the process is standardized and can be mass-produced; the finished product is sweet and sour, palatable, and replenishes qi without causing dryness; suitable for use in tea, pastries, and infused liquors, among other applications.

The invention relates to the technical field of plant tissue culture, in particular to a tissue culture and rapid propagation method for lilium marginatum and application of the tissue culture and rapid propagation method for lilium marginatum, a non-lignified tender stem section is selected as an explant, the cleaned explant is disinfected with 75% alcohol, 0.01% mercury bichloride and 0.05% mercury bichloride in sequence, the disinfected explant is inoculated into a primary culture medium for culture, and the primary culture medium is inoculated with a culture medium for culture; cluster buds obtained after primary culture are cut into single buds to be inoculated into a subculture medium to be cultured, subcultured cluster buds are cut into single buds to be inoculated into a rooting medium to be cultured, the primary induction rate reaches 83%, the subculture multiplication coefficient is 6 or above, and the rooting rate reaches 99% or above.

This invention belongs to the field of traditional Chinese medicine technology, and specifically relates to a traditional Chinese medicine composition and its preparation method for anti-fatigue and anti-aging. The traditional Chinese medicine composition of this invention includes Codonopsis pilosula, Polygonatum sibiricum, Rehmannia glutinosa, Lilium brownii, Poria cocos, donkey-hide gelatin, Dendrobium nobile, Ophiopogon japonicus, Cinnamomum cassia, Dioscorea opposita, Glycyrrhiza uralensis, Zingiber officinale, and Ziziphus jujuba. This invention utilizes the above-mentioned traditional Chinese medicinal materials in combination, which has good conditioning and maintenance effects on harmonizing Qi and blood, balancing Yin and Yang, replenishing Qi and nourishing blood, enhancing the digestive functions of the five internal organs, maintaining and reducing muscle and bone loss, alleviating fatigue intensity, and slowing down the aging process. Furthermore, the traditional Chinese medicine composition of this invention is a pure traditional Chinese medicine formula, with high safety and definite efficacy, and has broad application prospects in the field of anti-fatigue and anti-aging maintenance.

This invention relates to traditional Chinese medicine food, specifically to a traditional Chinese medicine exercise stick for preventing difficulty opening the mouth and its preparation method. The exercise stick comprises the following components: 10-30g of Codonopsis pilosula, 15-25g of Scrophularia ningpoensis, 10-25g of Ophiopogon japonicus, 10-20g of Rehmannia glutinosa, 10-20g of Schisandra chinensis, 15-25g of Astragalus membranaceus, 10-15g of Lilium brownii, 5-15g of Glycyrrhiza uralensis, and 60-120g of honey. The preparation method includes the following steps: decoct Codonopsis pilosula, Scrophularia ningpoensis, Ophiopogon japonicus, Rehmannia glutinosa, Schisandra chinensis, Astragalus membranaceus, Lilium brownii, and Glycyrrhiza uralensis twice with water according to the prescribed amounts, filter to obtain the liquid; add honey, mix evenly, and freeze to form the exercise stick. This invention's exercise stick, with its effects of invigorating qi, nourishing yin, and promoting body fluid production, prevents and alleviates tissue restriction, helps patients perform mouth-opening exercises, improves patient compliance, ensures smooth radiotherapy, and improves the quality of life for cancer patients.

The invention provides a traditional Chinese medicine composition for treating chronic pharyngitis, a traditional Chinese medicine preparation and a preparation method thereof, and the traditional Chinese medicine composition comprises the following components in parts by weight: 2-80 parts of physalis alkekengi, 1-70 parts of sugarcane, 1-60 parts of laver, 1-50 parts of lily, 1-50 parts of American ginseng, 1-50 parts of pseudo-ginseng, 1-40 parts of pericarpium citri reticulatae, 1-40 parts of semen coicis and 1-40 parts of lotus seed. The invention further provides a traditional Chinese medicine preparation for treating chronic pharyngitis and a preparation method thereof. The traditional Chinese medicine composition has a remarkable curative effect on chronic pharyngitis, the raw materials of the traditional Chinese medicine composition are all medicinal and edible varieties, are high in safety, free of toxicity and side effects, wide in raw material source, easy to obtain and suitable for being taken for a long time, and the preparation method of the traditional Chinese medicine composition is easy and convenient to operate, can achieve large-scale industrial production and is beneficial to industrial application of the composition.

The invention relates to the technical field of biology, in particular to application of bacillus velezensis F3A and wettable powder to prevention and treatment of Lanzhou lily fusarium wilt and application of the bacillus velezensis F3A and wettable powder to promotion of Lanzhou lily growth, the bacillus velezensis F3A is preserved in China General Microbiological Culture Collection Center on December 21, 2020, the preservation number is CGMCC No.21518, and the preservation number is CGMCC No.21518; the bacterial inhibition rate of the bacillus velezensis F3A on the Lanzhou lily wilt pathogenic bacterium fusarium tripterygium reaches 75.23%, and fermentation liquor effectively inhibits mycelial growth and spore germination of the fusarium tripterygium and can be stably colonized at the root system and bulb of the Lanzhou lily. The invention discloses a formula of bacillus velezensis F3A wettable powder. The bacillus velezensis F3A wettable powder disclosed by the invention has a relatively good growth promoting effect on Lanzhou lilium brownii, can be used for effectively preventing and treating fusarium wilt, and has a relatively good market application prospect.

This invention discloses a traditional Chinese medicine composition for regulating sub-health conditions and its preparation method, belonging to the technical field of traditional Chinese medicine compositions. This composition is made from a specific weight ratio of raw materials including Asparagus cochinchinensis, Lilium brownii, Poria cocos, Triticum aestivum, Polygonatum sibiricum, Morus alba, Black sesame, Walnut, Ginseng, Lycium barbarum, Angelica dahurica, Rose, Jujube, Honey, Citrus medica, Tangerine peel, Lotus seed, Prunus persica, Amomum villosum, Chrysanthemum morifolium, Hawthorn, Dioscorea opposita, Pueraria lobata, and Coix lacryma-jobi, with optional addition of natural Vitamin C. Based on the principles of traditional Chinese medicine (TCM) theory of monarch, minister, assistant, and guide herbs, this invention has the effects of invigorating Qi and nourishing Yin, strengthening the spleen and removing dampness, soothing the liver and regulating Qi, nourishing blood and calming the mind, and moisturizing the skin and beautifying the complexion. It effectively improves sub-health symptoms such as insomnia, fatigue, loss of appetite, and excessive dampness. This invention is suitable for people with difficulty swallowing and those requiring rapid onset of action. All dosage forms maintain the characteristics of mild medicinal properties, safety without side effects, simple preparation, and convenient administration, making it suitable for long-term daily conditioning and showing good application prospects.

This invention discloses a novel use of Artemisia annua seeds, a medicinal and edible compound composition for relieving hangovers and protecting the liver, chewable tablets, and their preparation process. This invention is the first to discover that the mucilage in Artemisia annua seeds slows down ethanol diffusion through a dual mechanism of physical adsorption and three-dimensional network blockage, thus slowing down the rate of ethanol absorption in the digestive tract, reducing the peak blood plasma concentration, and delaying or prolonging the time of intoxication. Therefore, it can be used in the preparation of health products / functional foods that protect the stomach, prevent intoxication, and delay alcohol absorption. Based on this discovery, this invention provides a medicinal and edible compound composition for relieving hangovers and protecting the liver, composed of 10-15 parts by weight of Pueraria lobata, 10-15 parts by weight of Hovenia dulcis, 8-10 parts by weight of Lilium brownii, 4-8 parts by weight of Poria cocos, 4-8 parts by weight of Dioscorea opposita, and 4-8 parts by weight of Artemisia annua seeds. Furthermore, to balance rapid effectiveness and compliance, it is formulated as a chewable tablet. This chewable tablet can significantly prolong the time of intoxication and shorten the sobering-up time, and is significantly superior to the group lacking Artemisia annua seeds in terms of antioxidant indicators (SOD, GSH, MDA) and hangover relief effect.

The invention discloses a Qingli decoction traditional Chinese medicine composition as well as a preparation method and application thereof, and relates to the field of Qingli decoction, the Qingli decoction traditional Chinese medicine composition comprises the following raw materials in parts by weight: 15 parts of radix scrophulariae, 12 parts of radix ophiopogonis, 12 parts of lily, 8 parts of radix bupleuri, 12 parts of radix paeoniae alba, 7 parts of pericarpium citri reticulatae, 7 parts of semen brassicae, 12 parts of selfheal, 7 parts of caulis bambusae in taeniam, 12 parts of semen plantaginis, 7 parts of akebiaquinata, 7 parts of radix gentianae and 5 parts of rhizoma coptidis. According to the Qingli decoction traditional Chinese medicine composition as well as the preparation method and the application thereof, thirteen medicinal materials including radix scrophulariae, radix ophiopogonis and the like which have definite effects of clearing heat and causing diuresis are selected and combined through scientific compatibility and optimization principles. The medicinal materials cooperate with one another to jointly exert the effects of clearing away heat and toxic materials and inducing diuresis to reduce edema, and the traditional Chinese medicine is accurately used for treating the symptoms such as cough, excessive phlegm, swollen sore throat and difficult urination caused by lung heat and damp-heat downward flow. Through scientific compatibility, the problem that the curative effect difference between different batches or patients is large due to lack of scientific verification and optimization of a traditional compound is avoided, and the high efficiency and stability of the formula are ensured.

The invention provides a traditional Chinese medicine composition for promoting embryo implantation as well as a preparation method and application thereof, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 5-30 parts of schisandra chinensis, 5-50 parts of semen cuscutae, 5-50 parts of parasitic loranthus, 5-50 parts of fructus lycii, 5-60 parts of astragalus membranaceus, 5-50 parts of radix pseudostellariae, 5-50 parts of bighead atractylodes rhizome, 5-50 parts of Chinese yam, 5-50 parts of lotus seeds, 5-30 parts of salvia miltiorrhiza and 5-30 parts of lily. The components of the traditional Chinese medicine composition are scientifically compatible and have a synergistic effect, the traditional Chinese medicine composition is applied in an embryo periimplantation period, a patient is clinically guided to start to take medicine after B-ultrasonic monitoring of mature ovum discharge or monitoring of basal body temperature entering a high-temperature phase, the problem of female infertility caused by embryo implantation disorder of the patient is solved, and the traditional Chinese medicine composition has a good clinical application prospect. The traditional Chinese medicine has a good treatment effect on female infertility, and is simple in preparation method, remarkable in curative effect and free of toxic and side effects.

The invention discloses a traditional Chinese medicine compound preparation for treating nephrotic syndrome and a preparation method of the traditional Chinese medicine compound preparation, and belongs to the technical field of nephrotic syndrome treatment.The synbiotic microcapsule is prepared by compatibility of traditional Chinese medicines such as safflower, scutellaria baicalensis and perilla frutescens, and the synbiotic microcapsule is prepared by embedding traditional Chinese medicine extracts such as astragalus membranaceus and lily with lactobacillus acidophilus and bifidobacterium; and the wall material is prepared from mannose grafted meadowfoam seed extract, sodium alginate and fucoidin sulfate. The synbiotics microcapsule utilizes a Maillard reaction modified wall material to enhance gastric acid erosion resistance, realizes intestinal targeted colonization through mannose residues, protects probiotics, directionally releases traditional Chinese medicine active components, adjusts intestinal flora balance and inhibits uremia toxin generation. The traditional Chinese medicine components such as the safflower and the scutellaria baicalensis improve kidney blood circulation, relieve inflammatory response and regulate lipid metabolism by inhibiting an NF-kappa B channel, activating an AMPK channel and the like; the components such as the Chinese yam and the Chinese wolfberry can repair the permeability of glomerular basement membrane and improve the hypoproteinemia.

This invention provides a fermented traditional Chinese medicine powder for women, which is related to the field of pharmaceutical technology. Based on dry weight, it is composed of the following raw materials: Astragalus membranaceus 15 parts, Citrus aurantium 9 parts, Polygonatum odoratum 9 parts, Angelica dahurica 6 parts, Longan aril 12 parts, Lilium brownii 6 parts, Lycium barbarum 12 parts, Poria cocos 9 parts, Nelumbo nucifera 9 parts, Lophatherum gracile 6 parts, Polygonatum sibiricum 15 parts, Morus alba 15 parts, Pueraria lobata 9 parts, Ziziphus jujuba var. spinosa 6 parts, Angelica sinensis 9 parts, Ganoderma lucidum 15 parts, and Ziziphus jujuba 9 parts. The powder is produced through solid-state fermentation with compound probiotics, low-temperature drying, ultra-fine pulverization, and irradiation sterilization. The fermented Chinese herbal powder for women, which is a formula for replenishing qi and blood, provided by this invention, solves the problems of poor targeting and insufficient precision in conditioning of existing tonifying medicines for women's physiological characteristics. It can effectively improve the sub-health state of women caused by insufficient qi and blood, deficiency of yin fluids, and restlessness, such as insomnia, dreaminess, sallow complexion, dull skin, fatigue, dizziness, and palpitations.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a pharmaceutical composition for treating simple obesity of spleen deficiency and dampness retention type and its application. This pharmaceutical composition is prepared based on seven traditional Chinese medicines listed in the Food and Drug Catalogue: Codonopsis pilosula, Poria cocos, Coix lacryma-jobi, Dioscorea opposita, Nelumbo nucifera, Lilium brownii, and Ziziphus jujuba. The pharmaceutical composition provided by this invention improves the condition of swollen, pale, and white-coated tongue in rats with simple obesity of spleen deficiency and dampness retention type, and improves abnormal lipid metabolism; it can effectively regulate abnormalities in serum BUN, UA, MTL, VIP, and other indicators in rats with simple obesity of spleen deficiency and dampness retention type, improve gastrointestinal emptying, enhance gastrointestinal motility, and increase the calcium content of myocardial cell membranes. 2+ -ATPase, Na + -K + - It increases ATPase activity, improves cellular energy metabolism, and reduces the risk of cardiovascular disease caused by obesity; it inhibits the expression levels of BUN and UA, which can treat obesity-induced hyperuricemia and improve renal metabolism. It also exerts a therapeutic effect on simple obese rats with spleen deficiency and dampness retention.

The invention belongs to the technical field of lily polysaccharide extraction, and particularly relates to lily polysaccharide, a composition as well as a preparation method and application of the lily polysaccharide. The lilium brownii polysaccharide extraction method comprises the following steps: (1) pretreatment: pretreating lilium brownii by high-energy electron beam irradiation; (2) enzymolysis: adding water into the pretreated lilies, and adding a compound enzyme composed of cellulase, pectinase and beta-glucanase for enzymolysis to obtain an enzymatic hydrolysate; and (3) deproteinization: loading the enzymatic hydrolysate to an AB-8 resin column, eluting with distilled water, and drying the eluent to obtain the deproteinization product. Wherein the dose of the high-energy electron beam irradiation in the step (1) is 40-240 kGy. According to the method, the lilies are subjected to pretreatment through high-energy electron beam irradiation, enzymolysis with the compound enzyme and deproteinization with the macroporous resin column, and the prepared lily polysaccharide is high in extraction efficiency, purity and safety and good in immunocompetence.

The invention discloses a pharmaceutical composition for prolonging life and preserving health. The traditional Chinese medicine composition comprises the following components: prepared rehmannia root, polygonum multiflorum, herba epimedii, male silkworm moth, schisandra chinensis, tribulus terrestris, dried ginger, angelica sinensis, bighead atractylodes rhizome, liquorice, cistanche, rhizoma cibotii, pseudo-ginseng, winter wheat, dendrobe, pericarpium citri reticulatae, glossy privet fruit, poria cocos, eucommia ulmoides, ligusticum chuanxiong hort, rhizoma alismatis, cudweed, lily, tendril-leaved fritillary bulb, rhizoma anemarrhenae, spina date seed, coix seed, medicated leaven, astragalus membranaceus, morinda officinalis, endothelium corneum gigeriae galli, musk, raspberry, codonopsis pilosula, phellinus igniarius, gecko, scorpion and ground beetle. A femtosecond wall breaking technology is combined with an ancient processing method, and medicated leaven is used for double fermentation, so that the medicine effect is improved by 8-10 times; the antioxidant capacity of the body can be improved, free radicals, immune functions and nerve protection functions are eliminated, and senescence is delayed; the medicine can treat old and chronic diseases. The preparation forms comprise decoction, oral liquid, pills and medicinal liquor. The composition can significantly improve the activity of antioxidant enzymes such as SOD, CAT and the like, reduce the MDA content and improve the cognitive and athletic ability.

This application discloses a traditional Chinese medicine preparation for use in a fumigation device and its preparation method, belonging to the field of traditional Chinese medicine preparation technology. The traditional Chinese medicine preparation for the fumigation device, by weight, comprises the following raw materials: Rehmannia glutinosa, Cornus officinalis, Dioscorea opposita, Poria cocos, Ziziphus jujuba var. spinosa, Lilium brownii, Ostrea gigas, Albizia julibrissin, Rosa rugosa, Mentha haplocalyx, Polygonum multiflorum, and Citrus medica. The preparation includes a compound essential oil and a traditional Chinese medicine granule carrier. The granule carrier is impregnated with the compound essential oil to obtain the preparation for the fumigation device. The mass ratio of the compound essential oil to the granule carrier is (5-8):100. By limiting the composition and ratio of the components of the traditional Chinese medicine preparation, synergistic effects between the drugs are achieved to improve insomnia, anxiety, depression, and other conditions. The compound essential oil and the granule carrier together form the preparation, avoiding the drawbacks of easy spillage and difficulty in transportation and storage associated with traditional Chinese medicine fumigation. This ensures the uniform and continuous release of effective components, preventing insufficient release of effective components in the later stages of fumigation.